Form D · Biotechnology
Duet Therapeutics, Inc.
Skillman, NJ · CIK 0001968644
Offering snapshot reported Mar 8, 2023 · SEC filing
- Reported sold
- $200K Offering amount: $1M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 16, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 8, 2023 | Initial | $200,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $14K
- Finders' fees
- $0
- Form D file number
- 021-475265
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Walter Greenblatt | 4723413 | Walter Greenblatt & Associates LLC · CRD 129291 |
Source: Form D, filed Mar 8, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Simon Tomlinson | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
23 Southern Hills Dr.
Skillman, NJ, 08558
Skillman, NJ, 08558